The potential impact of pharmacogenetic testing on medication adherence.
Pharmacogenomics J
; 13(6): 481-3, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-23999596
ABSTRACT
Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication-taking behavior.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Farmacogenética
/
Cooperação do Paciente
Limite:
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article